Anixa Biosciences Inc
Clinical-stage biotech developing CAR-T immunotherapies and vaccines to fight cancer.
ANIX | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 3150 ALMADEN EXPRESSWAY, SUITE 250, 95118 SAN JOSE
- Website:
- https://www.anixa.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Anixa Biosciences, Inc. is a clinical-stage biotechnology company focused on developing novel therapies and vaccines for the treatment and prevention of cancer. The company's pipeline addresses critical unmet needs in oncology through two primary platforms. Its therapeutics program is advancing a Chimeric Antigen Receptor T-cell (CAR-T) based immunotherapy, which genetically engineers a patient's own immune cells to fight cancer. Concurrently, its vaccine division is developing a portfolio of cancer vaccines, with programs for breast and ovarian cancer, as well as discovery-stage initiatives for other malignancies, including lung, colon, and prostate cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Anixa Biosciences Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Anixa Biosciences Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Anixa Biosciences Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
